Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 210

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor–associated periodic syndrome

Dodé, Catherine, André, Marc, Bienvenu, Thierry, Hausfater, Pierre, Pêcheux, Christophe, Bienvenu, Jacques, Lecron, Jean‐Claude, Reinert, Philippe, Cattan, Daniel, Piette, Jean‐Charles, Szajnert, Marie‐France, Delpech, Marc, Grateau, Gilles, French Hereditary Recurrent Inflammatory Disorder Study Group · 2002 · Arthritis & Rheumatism

Abstract

Objective: To characterize the frequency, clinical signs, and genotypic features of tumor necrosis factor receptor–associated periodic syndrome (TRAPS) in a series of 394 patients of various ethnic origins who have recurrent inflammatory syndromes. Methods: Sequencing of the coding region of the TNFRSF1A gene was performed in 128 patients in whom there was a high suspicion of TRAPS, and denatured high‐performance liquid chromatography was used to systematically screen for TNFRSF1A in 266 patients with recurrent inflammatory syndrome and no or only 1 Mediterranean fever gene (MEFV) mutation. Results: TNFRSF1A mutations were found in 28 (7.1%) of 394 unrelated patients. Nine (32%) of the 28 patients had a family history of recurrent inflammatory syndromes. In 13 patients, the length of the attack of inflammation was fewer than 5 days. Three of the mutations (Y20H, L67P, and C96Y) were novel. Two mutations, R92Q and (mainly) P46L, found in 12 and 10 patients, respectively, had lower penetrance compared with other mutations. TNFRSF1A mutations were found in patients of various ethnic origins, including those at risk for familial Mediterranean fever (FMF): Armenians, Sephardic Jews, and especially Arabs from Maghreb. Only 3 (10.7%) of the 28 patients had amyloidosis. Conclusion: TRAPS is an underdiagnosed cause of recurrent inflammatory syndrome. Its presence in the population of persons of Mediterranean ancestry and the short duration of the attacks of inflammation can lead to a fallacious diagnosis of FMF. Because an accurate diagnosis in patients with recurrent inflammatory syndromes is crucial for proper clinical management and treatment, genetic screening for TNFRSF1A is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.10429

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 210

Metadata

Authors
Dodé, C., André, M., Bienvenu, T., Hausfater, P., Pêcheux, C., Bienvenu, J., Lecron, J., Reinert, P., Cattan, D., Piette, J., Szajnert, M., Delpech, M., Grateau, G., & French Hereditary Recurrent Inflammatory Disorder Study Group
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2002-08
Volume
46
Issue
8
Pages
2181-2188
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2079672251
Cited by
210
References
1
FWCI
5.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor–associated periodic syndrome. https://app.cochat.ai/papers/10.1002/art.10429
The paper
Dodé, C., André, M., Bienvenu, T., Hausfater, P., Pêcheux, C., Bienvenu, J., Lecron, J., Reinert, P., Cattan, D., Piette, J., Szajnert, M., Delpech, M., Grateau, G., & French Hereditary Recurrent Inflammatory Disorder Study Group. (2002). The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor–associated periodic syndrome. Arthritis & Rheumatism. https://doi.org/10.1002/art.10429

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.